{"allTrials": {"@totalCount": "2", "@xmlns": "http://www.67bricks.com/isrctn", "fullTrial": [{"trial": {"@lastUpdated": "2012-11-12T00:00:00.000Z", "@version": "21", "isrctn": {"@dateAssigned": "2007-01-29T00:00:00.000Z", "#text": "88407981"}, "trialDescription": {"@thirdPartyFilesAcknowledgement": "false", "acknowledgment": "true", "title": "Axial IntraOcular Lens position and posterior capsule opacification with a microincisional single-piece open-loop hydrophilic IntraOcular Lens: a randomised trial (XCelens Idea versus single-piece Acrysof IntraOcular Lens)", "scientificTitle": null, "acronym": null, "studyHypothesis": "To assess the axial stability and the Posterior Capsule Opacification (PCO) inhibiting efficacy of a 360\u00b0 sharp edge hydrophilic IntraOcular Lens (IOL) (Idea, XCelens) and compare it to that of a standard hydrophobic acrylic IOL (Acrysof SA60AT, Alcon) both single-piece open-loop in design with sharp optic edges.", "plainEnglishSummary": "Not provided at time of registration", "primaryOutcome": "Posterior Capsule Opacification (PCO), measured with an image analysis system Automated QUantification of After-cataract (AQUA), scale zero to ten, from digital retroillumination photographs of the posterior capsule at two years.", "secondaryOutcome": "1. Anterior chamber depth (mm) with ACMaster\n2. Decentration (mm)\n3. Refraction\n4. Rhexis size (mm^2)\n5. Slitlamp biomicroscopy (descriptive)", "trialWebsite": null, "ethicsApprovalRequired": "Old ethics approval format", "ethicsCommittees": null, "ethicsApproval": "Approved by Moorfields and Whittington LREC on the 15th November 2006 (ref: 06/Q0504/96)."}, "externalRefs": {"doi": "10.1186/ISRCTN88407981", "eudraCTNumber": null, "irasNumber": null, "clinicalTrialsGovNumber": null, "protocolSerialNumber": "FINO1001"}, "trialDesign": {"studyDesign": "Randomised, bilateral, double-masked clinical trial with intra-individual comparison", "primaryStudyDesign": "Interventional", "secondaryStudyDesign": "Randomised controlled trial", "trialSettings": {"trialSetting": "Hospital"}, "trialTypes": {"trialType": "Treatment"}, "overallStatusOverride": null, "reasonAbandoned": null, "overallStartDate": "2006-11-28T00:00:00.000Z", "overallEndDate": "2009-05-28T00:00:00.000Z"}, "participants": {"recruitmentCountries": {"country": ["Austria", "England", "United Kingdom"]}, "trialCentres": {"trialCentre": {"@id": "b31dc8e3-a069-42bf-a12a-3e4e19c8ca28", "name": "Moorfields Eye Hospital NHS Foundation Trust", "address": null, "city": "London", "state": null, "country": "United Kingdom", "zip": "EC1V 2PD"}}, "participantTypes": {"participantType": "Patient"}, "inclusion": "1. Bilateral age-related cataract\n2. Age 40 and older\n3. Visual Acuity more than 0.05\n4. Normal findings in the medical history and physical examination unless the investigator   considers an abnormality to be clinically irrelevant\n5. Written informed consent to surgery and participation in the study", "ageRange": "Adult", "gender": "Not Specified", "targetEnrolment": "35", "totalFinalEnrolment": null, "totalTarget": "35 (70 eyes)", "exclusion": "Relevant other ophthalmic diseases (such as pseudoexfoliation, glaucoma, retinal degenerations, ocular trauma, etc.)", "patientInfoSheet": null, "recruitmentStart": "2006-11-28T00:00:00.000Z", "recruitmentEnd": "2009-05-28T00:00:00.000Z", "recruitmentStatusOverride": null}, "conditions": {"condition": {"description": "Cataract; posterior capsular opacification", "diseaseClass1": "Eye Diseases", "diseaseClass2": "Cataract"}}, "interventions": {"intervention": {"description": "Intraocular lens implant (XCelens Idea or Acrysof)", "interventionType": "Other", "pharmaceuticalStudyTypes": null, "phase": "Not Specified", "drugNames": null}}, "results": {"publicationPlan": "Not provided at time of registration", "ipdSharingStatement": null, "dataPolicies": {"dataPolicy": "Not provided at time of registration"}, "publicationDetails": "2011 Results article in http://www.ncbi.nlm.nih.gov/pubmed/21907536 results", "publicationStage": "Results", "biomedRelated": "false", "basicReport": null, "plainEnglishReport": null}, "outputs": {"output": {"@id": "757c7af6-d70c-402a-82eb-cffc7d2a0557", "@outputType": "resultsarticle", "@artefactType": "ExternalLink", "@dateCreated": "2011-11-01T00:00:00.000Z", "@dateUploaded": "", "@peerReviewed": "true", "@patientFacing": "false", "@createdBy": "Data migration", "externalLink": {"@url": "http://www.ncbi.nlm.nih.gov/pubmed/21907536"}, "description": "results", "productionNotes": null}}, "parties": {"funderId": "Funder15909-0", "contactId": "Contact53853_15909", "sponsorId": "Sponsor52404"}, "miscellaneous": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "ipdSharingPlan": "No"}, "attachedFiles": null}, "contact": {"@id": "Contact53853_15909", "title": "Mr", "forename": "Oliver", "surname": "Findl", "orcid": null, "contactTypes": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "contactType": "Scientific"}, "contactDetails": {"address": "Moorfields Eye Hospital NHS Foundation Trust\n162 City Road", "city": "London", "country": "United Kingdom", "zip": "EC1V 2PD", "telephone": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "+44 (0)20 7566 2036"}, "email": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "oliver.findl@moorfields.nhs.uk"}}, "privacy": "Public"}, "sponsor": {"@id": "Sponsor52404", "organisation": "Moorfields Eye Hospital NHS Foundation Trust (UK)", "website": "http://www.moorfields.nhs.uk/Home", "sponsorType": "Hospital/treatment centre", "contactDetails": {"address": "162 City Road", "city": "London", "state": "England", "country": "United Kingdom", "zip": "EC1V 2PD", "telephone": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions"}, "email": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions"}}, "privacy": "Protected", "gridId": "grid.436474.6", "rorId": "https://ror.org/03zaddr67"}, "funder": {"@id": "Funder15909-0", "name": "XCelens SA (Switzerland)", "fundRef": null}}, {"trial": {"@lastUpdated": "2012-11-12T00:00:00.000Z", "@version": "23", "isrctn": {"@dateAssigned": "2005-11-15T00:00:00.000Z", "#text": "07330512"}, "trialDescription": {"@thirdPartyFilesAcknowledgement": "false", "acknowledgment": "true", "title": "Screening and Counseling for physical Activity and Mobility in Older people", "scientificTitle": null, "acronym": "SCAMOB", "studyHypothesis": "Physical activity counseling promotes physical activity, prevents mobility limitation and disability in older people.", "plainEnglishSummary": "Not provided at time of registration", "primaryOutcome": "1. Physical activity level\n2. Functional impairments\n3. Mobility limitation\n4. Disability\n5. Quality of life", "secondaryOutcome": "1. Use of health and social services\n2. Institutionalisation \n3. Mortality", "trialWebsite": null, "ethicsApprovalRequired": "Old ethics approval format", "ethicsCommittees": null, "ethicsApproval": "Not provided at time of registration."}, "externalRefs": {"doi": "10.1186/ISRCTN07330512", "eudraCTNumber": null, "irasNumber": null, "clinicalTrialsGovNumber": null, "protocolSerialNumber": "Ministry of Education: 104/22/2004; Ministry of Social Affairs and Health: 09/TER/2005"}, "trialDesign": {"studyDesign": "Randomised controlled trial", "primaryStudyDesign": "Interventional", "secondaryStudyDesign": "Randomised controlled trial", "trialSettings": {"trialSetting": "Not specified"}, "trialTypes": {"trialType": "Screening"}, "overallStatusOverride": null, "reasonAbandoned": null, "overallStartDate": "2003-03-31T00:00:00.000Z", "overallEndDate": "2007-12-31T00:00:00.000Z"}, "participants": {"recruitmentCountries": {"country": "Finland"}, "trialCentres": {"trialCentre": {"@id": "aaa28ce3-305e-40e7-b896-e97b553dbc68", "name": "Finnish Centre for Interdisciplinary Gerontology", "address": null, "city": "Jyv\u00e4skyl\u00e4", "state": null, "country": "Finland", "zip": "FIN-40014"}}, "participantTypes": {"participantType": "Patient"}, "inclusion": "Cognitively intact community-living older people; the study group consisted of all the 75 - 81 year-old people living in the city center area in Jyv\u00e4skyl\u00e4, Finland. The inclusion criteria were set as follows:\n1. The ability to walk at least 0.5 km without assistance\n2. Only moderately physically active or sedentary\n3. No memory impairment (Mini Mental State Examination [MMSE] greater than 21)\n4. No medical contraindications for physical activity\n5. Informed consent to participate", "ageRange": "Senior", "gender": "Both", "targetEnrolment": "1310", "totalFinalEnrolment": null, "totalTarget": "Target population n = 1310, study group n = 632", "exclusion": "Those with severe mobility limitation (not able to walk 0.5 km independently), and those who were physically active (greater than 4 exercise a week), were excluded. In addition, subjects with MMSE points less than 22 were excluded.", "patientInfoSheet": null, "recruitmentStart": "2003-03-31T00:00:00.000Z", "recruitmentEnd": "2007-12-31T00:00:00.000Z", "recruitmentStatusOverride": null}, "conditions": {"condition": {"description": "Mobility limitation", "diseaseClass1": "Signs and Symptoms", "diseaseClass2": "Mobility limitation"}}, "interventions": {"intervention": {"description": "The intervention comprised a physical activity counseling session together with a physiotherapist followed by regular phone contacts four times a year throughout the two-year intervention. We promoted use of existing exercise services available for older people which are available for the participants also after finishing the project. The control group received no intervention. Physical activity, health and mobility were followed-up in three biannual telephone interviews in both the intervention and control group throughout the intervention. The follow-up interviews and physical assessments corresponding to those of baseline were done two years after the baseline in 2005. After these two-year follow-up examinations physical activity level and mobility limitation will be followed-up in three telephone interviews six months apart to the end of 2006. Follow-up of service use will continue until the end of the year 2007 and follow-up of institutionalisation and mortality until the death of the participant or 20 years; the data will be collected from population registers.", "interventionType": "Other", "pharmaceuticalStudyTypes": null, "phase": "Not Specified", "drugNames": null}}, "results": {"publicationPlan": "Not provided at time of registration", "ipdSharingStatement": null, "dataPolicies": {"dataPolicy": "Not provided at time of registration"}, "publicationDetails": "2007 Protocol article in http://www.ncbi.nlm.nih.gov/pubmed/17394477 protocol\n2011 Results article in http://www.ncbi.nlm.nih.gov/pubmed/20881453 results\n2012 Results article in http://www.ncbi.nlm.nih.gov/pubmed/21911336 results", "publicationStage": "Results", "biomedRelated": "false", "basicReport": null, "plainEnglishReport": null}, "outputs": {"output": [{"@id": "fa6d9cb9-35fe-468c-9376-f81b8bc08941", "@outputType": "protocolarticle", "@artefactType": "ExternalLink", "@dateCreated": "2007-04-01T00:00:00.000Z", "@dateUploaded": "", "@peerReviewed": "true", "@patientFacing": "false", "@createdBy": "Data migration", "externalLink": {"@url": "http://www.ncbi.nlm.nih.gov/pubmed/17394477"}, "description": "protocol", "productionNotes": null}, {"@id": "7a83af96-9824-4f1f-8b53-ba5771f514d9", "@outputType": "resultsarticle", "@artefactType": "ExternalLink", "@dateCreated": "2011-08-01T00:00:00.000Z", "@dateUploaded": "", "@peerReviewed": "true", "@patientFacing": "false", "@createdBy": "Data migration", "externalLink": {"@url": "http://www.ncbi.nlm.nih.gov/pubmed/20881453"}, "description": "results", "productionNotes": null}, {"@id": "94092060-f11e-4706-bba2-7c08dc14672c", "@outputType": "resultsarticle", "@artefactType": "ExternalLink", "@dateCreated": "2012-12-01T00:00:00.000Z", "@dateUploaded": "", "@peerReviewed": "true", "@patientFacing": "false", "@createdBy": "Data migration", "externalLink": {"@url": "http://www.ncbi.nlm.nih.gov/pubmed/21911336"}, "description": "results", "productionNotes": null}]}, "parties": {"funderId": ["Funder14127-0", "Funder14127-1", "Funder14127-2", "Funder14127-3"], "contactId": "Contact51807_14127", "sponsorId": "Sponsor50228"}, "miscellaneous": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "ipdSharingPlan": "No"}, "attachedFiles": null}, "contact": {"@id": "Contact51807_14127", "title": "Dr", "forename": "Raija", "surname": "Leinonen", "orcid": null, "contactTypes": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "contactType": "Scientific"}, "contactDetails": {"address": "Finnish Centre for Interdisciplinary Gerontology\nUniversity of Jyv\u00e4skyl\u00e4\nP.O. Box 35 (Viveca)", "city": "Jyv\u00e4skyl\u00e4", "country": "Finland", "zip": "FIN-40014", "telephone": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "+358 (0)14 260 2176"}, "email": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions", "#text": "raija.leinonen@sport.jyu.fi"}}, "privacy": "Public"}, "sponsor": {"@id": "Sponsor50228", "organisation": "Ministry of Education (Finland)", "website": "http://www.minedu.fi/OPM/?lang=en", "sponsorType": "Government", "contactDetails": {"address": "PL 29\n00023 Valtioneuvosto", "city": "Helsinki", "country": "Finland", "zip": "00023", "telephone": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions"}, "email": {"@xmlns:ssb": "http://www.67bricks.com/isrctn/functions"}}, "privacy": "Protected", "gridId": "grid.453525.0", "rorId": "https://ror.org/02w52zt87"}, "funder": [{"@id": "Funder14127-0", "name": "Ministry of Education (Finland)", "fundRef": "http://dx.doi.org/10.13039/501100002701"}, {"@id": "Funder14127-1", "name": "Ministry of Social Affairs and Health (Finland)", "fundRef": null}, {"@id": "Funder14127-2", "name": "City of Jyv\u00e4skyl\u00e4 (Finland)", "fundRef": null}, {"@id": "Funder14127-3", "name": "University of Jyv\u00e4skyl\u00e4 (Finland)", "fundRef": null}]}]}}